CLINICAL_TRIALS
trial_result
· 2025-09-12
Clinical Trial Update: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Summary
A Phase 3 trial evaluating BI 1015550 for improving lung function in idiopathic pulmonary fibrosis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2025-09-12